KINSHASA, Democratic Republic of the Congo / RankWire.AI / – Health authorities in the Democratic Republic of the Congo began administering Ebola vaccinations in Kisangani on Thursday, launching a targeted campaign in the capital of Tshopo Province to protect frontline responders. The initiative prioritizes healthcare workers, emergency response teams, and individuals with direct contact with confirmed patients as the country confronts its deadliest recorded Ebola outbreak. Health Minister Samuel-Roger Kamba confirmed that the government deployed an initial supply of the Ervebo vaccine under a compassionate-use framework across impacted eastern provinces to safeguard essential personnel and help disrupt viral transmission chains.
Official epidemiological data indicates that the ongoing outbreak has spread across six eastern provinces, including Ituri, North Kivu, South Kivu, Tshopo, Haut-Uele, and Bas-Uele. Public health figures published by the Ministry of Public Health and Prevention show that the country has recorded 5,713 confirmed cases and 2,744 deaths. The current overall case fatality rate among confirmed patients stands at approximately 48%.
The public health emergency has prompted international health agencies, including the World Health Organization, to support local medical teams with logistics, laboratory testing, and vaccine distribution. Authorities are administering the Ervebo vaccine under a compassionate-use framework while medical researchers gather observational data on its effectiveness against the viral strain circulating in the region. DR Congo launches Ebola vaccination campaign as health workers intensify ring-vaccination strategies around identified infection clusters to isolate viral transmission chains.
Health Ministry Focuses on Distributing Ervebo Vaccines to Healthcare Professionals in Kisangani
Logistical challenges persist due to complicated regional infrastructure, ongoing security concerns, and high mobility of populations across border districts, which complicate vaccine delivery. Cold-chain systems have been established in Kisangani to ensure that vaccines are stored at ultra-low temperatures before transportation to remote health zones. DR Congo has launched Ebola vaccination efforts while civil defense and community health workers carry out educational campaigns to improve disease surveillance and reporting.
Epidemiologists from the Africa Centres for Disease Control and Prevention are actively collaborating with local teams to monitor adverse effects and assess immune responses among vaccinated groups. Officials stress that early detection, combined with isolation procedures and supportive medical care, remains crucial for increasing patient survival chances. Additional vaccine shipments are expected as distribution expands to other regional health districts.
Authorities Reinforce Strict Infection Control Measures in Ebola Treatment Facilities
National teams continue expanding contact-tracing efforts across urban and rural zones within the eastern regions. Local health centers are receiving personal protective equipment, diagnostic reagents, and therapeutic supplies to boost readiness. The government confirmed that comprehensive public health actions will stay in effect until data shows a consistent decline in transmission rates across all affected provinces.
The government urges local communities to fully cooperate with mobile vaccination teams and follow established health protocols. It is anticipated that increasing immunization coverage among high-risk groups will help stabilize infection rates over the upcoming weeks. Monitoring efforts will remain heightened at transportation hubs and border crossings to prevent further geographic spread.